LGVN Q4 2021 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena

LGVNLongeveron Inc.

$20M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$209,000-82.3% YoY

Gross Profit

$69,00033.0% margin

Operating Income

-$4M-1929.2% margin

Net Income

-$4M-1946.9% margin

EPS (Diluted)

$-2.00

QoQ Revenue Growth

-9.9%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$43M

Total Liabilities

$5M

Stockholders' Equity

$37M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$209,000	$1M	-82.3%
Gross Profit	$69,000	$529,032	-87.0%
Operating Income	-$4M	-$1M	-191.5%
Net Income	-$4M	-$1M	-200.1%